Pneumococcal Pneumonia Prevention

Availability of a vaccine containing pneumococcal polysaccharide-specific antigen in 23 antigen, 85% -90% of serious pneumococcal infections of this type of pneumococcal serotypes. Although precise protection of water Ping is not yet understand, therefore, unable to make antibody titer determination But most children over 2 years of age and adults inoculated 2-3 weeks after antigen reaction. About 50% of the vaccinated patients developed at the injection site erythema and / or pain; About 1% of fever, muscle pain, or severe local reaction; 5% of the people there - like allergic reactions or other serious. repeat serious reactions after vaccination more common. General called for 2 years more children and incidence of pneumococcal disease and complications likely to be greater for the adult vaccination. Injection should also include slow diseases, particularly cardiovascular disease and lung disease; with splenic dysfunction or anatomical no spleen, Hodgkin's disease, Multiple myeloma, diabetes, HIV infection, liver cirrhosis, alcoholism, renal failure, Organ transplants and other immunosuppressive diseases related to the patient; suffering from nephrotic children; the elderly, particularly the aspects are normal, but over 65 years old, and the leakage of cerebrospinal fluid of patients. immunocompromised patients antibody response declined. Sickle cell anemia or other causes no spleen children, in addition to pneumococcal vaccine injection, It should also be vaccinated penicillin. recurrent upper respiratory tract infections (including sinusitis and otitis media) is not generally considered vaccinated Indications. Duration of protection is not yet understood, but it seems longer; For high-risk groups, Sometimes 5 to 10 years after vaccination would be repeated. 5 years were easy to repeat vaccination a strong local response.